Q1 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript
Good morning and welcome to the Quoin Pharmaceuticals' first-quarter financial results and business update conference call. (Operator Instructions) Please also note that this event is being recorded today.
I would now like to turn the conference over to Gordon Dunn, Chief Financial Officer. Please go ahead, sir.
Thank you, and good morning. We appreciate you joining us on today's conference call.
With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO. We're pleased to provide an update of our progress in the first quarter of 2023, as well as discussing our Q1 2023 financial results. Please note that our operational and financial results press release is now available on Quoin's website.
In keeping with our normal procedure, to begin, Michael will provide a corporate, clinical and operational update following which, I will review our Q1 financial results. I will then hand the call back to Michael for closing comments. We'll be pleased to answer any questions at the end of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |